EBF1-deficient bone marrow stroma elicits persistent changes in HSC potential

Crosstalk between mesenchymal stromal cells (MSCs) and hematopoietic stem cells (HSCs) is essential for hematopoietic homeostasis and lineage output. Here, we investigate how transcriptional changes in bone marrow (BM) MSCs result in long-lasting effects on HSCs. Single-cell analysis of Cxcl12-abundant reticular (CAR) cells and PDGFRα+Sca1+ (PαS) cells revealed an extensive cellular heterogeneity but uniform expression of the transcription factor gene Ebf1. Conditional deletion of Ebf1 in these MSCs altered their cellular composition, chromatin structure and gene expression profiles, including the reduced expression of adhesion-related genes. Functionally, the stromal-specific Ebf1 inactivation results in impaired adhesion of HSCs, leading to reduced quiescence and diminished myeloid output. Most notably, HSCs residing in the Ebf1-deficient niche underwent changes in their cellular composition and chromatin structure that persist in serial transplantations. Thus, genetic alterations in the BM niche lead to long-term functional changes of HSCs

Tristhienylphenylamine - extended dithiafulvene hybrids as bifunctional electroactive species

Extended hybrid conjugated systems based on a trithienylphenylamine core with 1, 2 and 3 peripheral dithiafulvenyl units have been synthesized and studied by cyclic voltammetry and UV-Vis. absorption spectroscopy. Theoretical calculations have also been undergone. The behaviour of these derivatives which depends on the number of dithiafulvene moieties grafted of the central core is cleared up. One polymer, obtained from derivative 3 presents polyelectrochromic properties

High WBP5 expression correlates with elevation of HOX genes levels and is associated with inferior survival in patients with acute myeloid leukaemia

WW domain binding protein 5 (WBP5), also known as Transcriptional Elongation Factor A like 9 (TCEAL9) has been proposed as a candidate oncogene for human colorectal cancers with microsatellite instability and as a predictive indicator of small cell lung cancers. Furthermore, several independent studies have proposed WBP5, and its association with Wilms Tumor-1 (WT1) expression, as part of a gene expression-based risk score for predicting survival and clinical outcome in patients with Acute Myeloid Leukaemia (AML). To date, the prognostic significance of the sole WBP5 expression and its impact on the survival outcome in AML patients remains largely understudied. In the present study, we have made use of publicly available patient expression arrays and have developed an unbiased approach to classify AML patients into low versus high WBP5 expressers and to balance them for known mutations and cytogenetic findings. Interestingly, we found that patients characterized by high WBP5 expression displayed inferior overall and event-free survival rates. Notably, gene expression profiling showed that patients with high WBP5 had elevated expression of several HOX cluster genes, such as HOXA5, HOXA7, HOXA9 and HOXA10, and several of their partner proteins, such as MEIS1 and FOXC1, which have been demonstrated to be causative for AML. Taken together, our data suggest that WBP5 expression level could serve as an indicator for prognosis and survival outcome in patients with AML

A nullstellensatz for sequences over F_p

Let p be a prime and let A=(a_1,...,a_l) be a sequence of nonzero elements in F_p. In this paper, we study the set of all 0-1 solutions to the equation a_1 x_1 + ... + a_l x_l = 0. We prove that whenever l >= p, this set actually characterizes A up to a nonzero multiplicative constant, which is no longer true for l < p. The critical case l=p is of particular interest. In this context, we prove that whenever l=p and A is nonconstant, the above equation has at least p-1 minimal 0-1 solutions, thus refining a theorem of Olson. The subcritical case l=p-1 is studied in detail also. Our approach is algebraic in nature and relies on the Combinatorial Nullstellensatz as well as on a Vosper type theorem.Comment: 23 page

Le traitement de l’entérite chronique hypertrophiante des Bovidés par les sulfones

Verge Jean, Goret Pierre, Cauchy Laurent. Le traitement de l’entérite chronique hypertrophiante. In: Bulletin de l'Académie Vétérinaire de France tome 104 n°2, 1951. pp. 97-99

Imaging-guided interventions modulating portal venous flow: Evidence and controversies

Portal hypertension is defined by an increase in the portosystemic venous gradient. In most cases, increased resistance to portal blood flow is the initial cause of elevated portal pressure. More than 90% of cases of portal hypertension are estimated to be due to advanced chronic liver disease or cirrhosis. Transjugular intrahepatic portosystemic shunts, a non-pharmacological treatment for portal hypertension, involve the placement of a stent between the portal vein and the hepatic vein or inferior vena cava which helps bypass hepatic resistance. Portal hypertension may also be a result of extrahepatic portal vein thrombosis or compression. In these cases, percutaneous portal vein recanalisation restores portal trunk patency, thus preventing portal hypertension-related complications. Any portal blood flow impairment leads to progressive parenchymal atrophy and triggers hepatic regeneration in preserved areas. This provides the rationale for using portal vein embolisation to modulate hepatic volume in preparation for extended hepatic resection. The aim of this paper is to provide a comprehensive evidence-based review of the rationale for, and outcomes associated with, the main imaging-guided interventions targeting the portal vein, as well as to discuss the main controversies around such approaches. (c) 2022 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/)

Stochastic Line-Motion and Stochastic Conservation Laws for Non-Ideal Hydromagnetic Models. I. Incompressible Fluids and Isotropic Transport Coefficients

We prove that smooth solutions of non-ideal (viscous and resistive) incompressible magnetohydrodynamic equations satisfy a stochastic law of flux conservation. This property involves an ensemble of surfaces obtained from a given, fixed surface by advecting it backward in time under the plasma velocity perturbed with a random white-noise. It is shown that the magnetic flux through the fixed surface is equal to the average of the magnetic fluxes through the ensemble of surfaces at earlier times. This result is an analogue of the well-known Alfven theorem of ideal MHD and is valid for any value of the magnetic Prandtl number. A second stochastic conservation law is shown to hold at unit Prandtl number, a random version of the generalized Kelvin theorem derived by Bekenstein-Oron for ideal MHD. These stochastic conservation laws are not only shown to be consequences of the non-ideal MHD equations, but are proved in fact to be equivalent to those equations. We derive similar results for two more refined hydromagnetic models, Hall magnetohydrodynamics and the two-fluid plasma model, still assuming incompressible velocities and isotropic transport coefficients. Finally, we use these results to discuss briefly the infinite-Reynolds-number limit of hydromagnetic turbulence and to support the conjecture that flux-conservation remains stochastic in that limit.Comment: 20 pages, no figures, submitted to J. Math. Phys